European Regulators Recommend Approval for Pharming Group's Joenja

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion regarding the marketing authorization for Joenja®. This regulatory milestone represents a significant step towards the drug's anticipated launch in Europe during 2026. The recommendation is expected to facilitate increased patient access to this therapy across the continent.